259 related articles for article (PubMed ID: 25565005)
21. ZEB2 in T-cells and T-ALL.
De Coninck S; Berx G; Taghon T; Van Vlierberghe P; Goossens S
Adv Biol Regul; 2019 Dec; 74():100639. PubMed ID: 31383581
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
23. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
24. Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
McClure BJ; Heatley SL; Kok CH; Sadras T; An J; Hughes TP; Lock RB; Yeung D; Sutton R; White DL
Br J Cancer; 2018 Apr; 118(7):1000-1004. PubMed ID: 29531323
[TBL] [Abstract][Full Text] [Related]
25. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.
Dominguez CX; Amezquita RA; Guan T; Marshall HD; Joshi NS; Kleinstein SH; Kaech SM
J Exp Med; 2015 Nov; 212(12):2041-56. PubMed ID: 26503446
[TBL] [Abstract][Full Text] [Related]
26. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
27. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Zhang J; Ding L; Holmfeldt L; Wu G; Heatley SL; Payne-Turner D; Easton J; Chen X; Wang J; Rusch M; Lu C; Chen SC; Wei L; Collins-Underwood JR; Ma J; Roberts KG; Pounds SB; Ulyanov A; Becksfort J; Gupta P; Huether R; Kriwacki RW; Parker M; McGoldrick DJ; Zhao D; Alford D; Espy S; Bobba KC; Song G; Pei D; Cheng C; Roberts S; Barbato MI; Campana D; Coustan-Smith E; Shurtleff SA; Raimondi SC; Kleppe M; Cools J; Shimano KA; Hermiston ML; Doulatov S; Eppert K; Laurenti E; Notta F; Dick JE; Basso G; Hunger SP; Loh ML; Devidas M; Wood B; Winter S; Dunsmore KP; Fulton RS; Fulton LL; Hong X; Harris CC; Dooling DJ; Ochoa K; Johnson KJ; Obenauer JC; Evans WE; Pui CH; Naeve CW; Ley TJ; Mardis ER; Wilson RK; Downing JR; Mullighan CG
Nature; 2012 Jan; 481(7380):157-63. PubMed ID: 22237106
[TBL] [Abstract][Full Text] [Related]
28. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.
Denecker G; Vandamme N; Akay O; Koludrovic D; Taminau J; Lemeire K; Gheldof A; De Craene B; Van Gele M; Brochez L; Udupi GM; Rafferty M; Balint B; Gallagher WM; Ghanem G; Huylebroeck D; Haigh J; van den Oord J; Larue L; Davidson I; Marine JC; Berx G
Cell Death Differ; 2014 Aug; 21(8):1250-61. PubMed ID: 24769727
[TBL] [Abstract][Full Text] [Related]
29. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
Fang Y; Wei J; Cao J; Zhao H; Liao B; Qiu S; Wang D; Luo J; Chen W
PLoS One; 2013; 8(5):e62558. PubMed ID: 23658743
[TBL] [Abstract][Full Text] [Related]
30. Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB.
Katoh M; Katoh M
Int J Oncol; 2009 Jun; 34(6):1737-42. PubMed ID: 19424592
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
33. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
[TBL] [Abstract][Full Text] [Related]
34. Placental Growth Factor Promotes Ovarian Cancer Cell Invasion via ZEB2.
Song N; Liu H; Ma X; Zhang S
Cell Physiol Biochem; 2016; 38(1):351-8. PubMed ID: 26824454
[TBL] [Abstract][Full Text] [Related]
35. Progesterone signaling/miR-200a/zeb2 axis regulates self-renewal of mouse embryonic stem cells.
Ai Y; Liu Q; Li Y; Duan T
Biomed Pharmacother; 2014 Mar; 68(2):201-8. PubMed ID: 24433831
[TBL] [Abstract][Full Text] [Related]
36. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
[TBL] [Abstract][Full Text] [Related]
37. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.
You J; Li Y; Fang N; Liu B; Zu L; Chang R; Li X; Zhou Q
PLoS One; 2014; 9(3):e91827. PubMed ID: 24626466
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
39. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
Xie R; Tang J; Zhu X; Jiang H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
[No Abstract] [Full Text] [Related]
40. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
